Some drug–method combinations that may be considered for treating corneal neovascularization include anti-VEGF + laser therapy (especially argon lasers), anti-VEGF + anti-inflammatory drugs (corticosteroids or NSAIDs if the neovascularization is associated with inflammation), anti-VEGF + causal treatment (autoimmune diseases, diabetes, or infection), anti-VEGF + photothermal therapy or PDT (photosensitizers and lasers), laser therapy + anti-inflammatory drugs, and multi-drug combinations. Here, VEGFA is linked to diabetes mellitus.